[HTML][HTML] Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised …
B Williams, TM MacDonald, S Morant, DJ Webb… - The Lancet, 2015 - thelancet.com
Background Optimal drug treatment for patients with resistant hypertension is undefined. We
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
[HTML][HTML] Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised …
B Williams, TM MacDonald, S Morant… - Lancet (London …, 2015 - ncbi.nlm.nih.gov
Background Optimal drug treatment for patients with resistant hypertension is undefined. We
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
[PDF][PDF] Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised …
B Williams, TM MacDonald, S Morant, DJ Webb… - 2015 - researchgate.net
Background Optimal drug treatment for patients with resistant hypertension is undefined. We
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double …
B Williams, TM MacDonald, S Morant, DJ Webb… - Lancet, 2015 - eprints.gla.ac.uk
Background: Optimal drug treatment for patients with resistant hypertension is undefined.
We aimed to test the hypotheses that resistant hypertension is most often caused by …
We aimed to test the hypotheses that resistant hypertension is most often caused by …
[PDF][PDF] Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised …
B Williams, TM MacDonald, S Morant, DJ Webb… - 2015 - academia.edu
Background Optimal drug treatment for patients with resistant hypertension is undefined. We
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
[PDF][PDF] Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised …
B Williams, TM MacDonald, S Morant, DJ Webb… - 2015 - Citeseer
Background Optimal drug treatment for patients with resistant hypertension is undefined. We
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
[HTML][HTML] Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised …
B Williams, TM MacDonald, S Morant… - Lancet (London …, 2015 - europepmc.org
Background Optimal drug treatment for patients with resistant hypertension is undefined. We
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double …
B Williams, TM MacDonald, S Morant, DJ Webb… - 2015 - pubmed.ncbi.nlm.nih.gov
Background Optimal drug treatment for patients with resistant hypertension is undefined. We
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
[PDF][PDF] Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised …
B Williams, TM MacDonald, S Morant, DJ Webb… - Lancet, 2015 - kclpure.kcl.ac.uk
Background Optimal drug treatment for patients with resistant hypertension is undefined. We
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double …
B Williams, TM MacDonald, S Morant, DJ Webb… - The …, 2015 - research.ed.ac.uk
Background: Optimal drug treatment for patients with resistant hypertension is undefined.
We aimed to test the hypotheses that resistant hypertension is most often caused by …
We aimed to test the hypotheses that resistant hypertension is most often caused by …